CN103908637A - 一种用于慢性前列腺炎坐浴的中药颗粒剂 - Google Patents
一种用于慢性前列腺炎坐浴的中药颗粒剂 Download PDFInfo
- Publication number
- CN103908637A CN103908637A CN201410154649.9A CN201410154649A CN103908637A CN 103908637 A CN103908637 A CN 103908637A CN 201410154649 A CN201410154649 A CN 201410154649A CN 103908637 A CN103908637 A CN 103908637A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine granule
- chronic prostatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 201000007094 prostatitis Diseases 0.000 title claims abstract description 21
- 239000008187 granular material Substances 0.000 title claims abstract description 16
- 208000013507 chronic prostatitis Diseases 0.000 title claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims abstract description 5
- 229910052623 talc Inorganic materials 0.000 claims abstract description 5
- 239000000454 talc Substances 0.000 claims abstract description 5
- 241000237903 Hirudo Species 0.000 claims description 4
- 241000237636 Pheretima Species 0.000 claims description 4
- 235000012222 talc Nutrition 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 18
- 230000001737 promoting effect Effects 0.000 abstract description 12
- 210000002307 prostate Anatomy 0.000 abstract description 10
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 230000003902 lesion Effects 0.000 abstract description 3
- 240000008027 Akebia quinata Species 0.000 abstract 1
- 235000007756 Akebia quinata Nutrition 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 241000555682 Forsythia x intermedia Species 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241001598107 Imperata Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 244000183278 Nephelium litchi Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 241000219061 Rheum Species 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 244000288377 Saxifraga stolonifera Species 0.000 abstract 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 230000008338 local blood flow Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 208000004880 Polyuria Diseases 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 10
- 230000035619 diuresis Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 230000001047 pyretic effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 210000003932 urinary bladder Anatomy 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 210000004908 prostatic fluid Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 206010057409 Prostate tenderness Diseases 0.000 description 1
- 206010036968 Prostatic pain Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003903 pelvic floor Anatomy 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000003689 pubic bone Anatomy 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000001148 spastic effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种用于慢性前列腺炎坐浴的中药颗粒剂,由以下中药原料按重量份研磨成粉末状,制成颗粒剂:连翘30、牡丹皮20、赤芍20、白茅根30、黄柏20、木通15、川牛膝15、虎耳草20、大黄30、丹参20、细辛10、王不留行20、败酱草40、荔枝核15、水蛭20、莪术20、琥珀粉20、滑石30、萹蓄20、地龙20。本发明诸药并用,共奏清热利湿、化淤散结之效。其重点在于实现前列腺局部的血液循环,以保证病变组织炎性分泌物能够被顺利地引流,实现了炎性反应以及病灶的彼此间的作用,有很好的临床效果。
Description
技术领域
本发明涉及一种用于慢性前列腺炎坐浴的中药颗粒剂。
背景技术
慢性前列腺炎(CP)是泌尿外科门诊最常见的疾病之一,分为慢性细菌性前列腺炎(chronic bacterial prostatitis,CBP)、慢性非细菌性前列腺炎(chronic nonbacterial prostatitis,CNP)。慢性前列腺炎的病因学十分复杂,尤其是近10年来,更是加大了对慢性前列腺炎研究的力度,但至今未取得突破性进展。
由于患者自我保健意识差、前列腺位置较深、前列腺中的血流量相对较少,前列腺是由外层纤维鞘和肌层组成的包膜所包裹,加上它的上皮的类脂膜,对大多数抗菌药物具有一种屏障作用,药物更难以透过包膜,进入腺体,致药物疗效欠佳。由于以上种种因素导致慢性前列腺炎迁延反复愈。
发明内容
本发明的目的是提供一种用于慢性前列腺炎坐浴的中药颗粒剂。
为实现上述目的,本发明采用的技术方案为:
一种用于慢性前列腺炎坐浴的中药颗粒剂,其特征是:由以下中药原料按重量份研磨成粉末状,制成颗粒剂:连翘30、牡丹皮20、赤芍20、白茅根30、黄柏20、木通15、川牛膝15、虎耳草20、大黄30、丹参20、细辛10、王不留行20、败酱草40、荔枝核15、水蛭20、莪术20、琥珀粉20、滑石30、萹蓄20、地龙20。
本发明诸药并用,共奏清热利湿、化淤散结之效。其重点在于实现前列腺局部的血液循环,以保证病变组织炎性分泌物能够被顺利地引流,实现了炎性反应以及病灶的彼此间的作用,有很好的临床效果。
本发明通过对患者治疗4~6周后,显效139例(82.73%),其中Ⅱ型29例,Ⅲ型116例;有效24例(14.28%),其中Ⅱ型3例,Ⅲ型21例;无效5例(2.97%),其中Ⅱ型1例,Ⅲ型4例。总有效率97.02%。
具体实施方式
下面结合具体实施例对本发明作进一步说明:
本发明中药原料配比(重量份):连翘30g、牡丹皮20g、赤芍20g、白茅根30g、黄柏20g、木通15g、川牛膝15g、虎耳草20g、大黄30g、丹参20g、细辛10g、王不留行20g、败酱草40g、荔枝核15g、水蛭20g、莪术20g、琥珀粉20g、滑石30g、萹蓄20g、地龙20g。
制备方法:上述诸药研磨成粉末状,做成颗粒剂。
治疗方法:所有患者规律性药物治疗4~6周的基础上,观察组行中药温水坐浴,将中药颗粒剂倒入盆中,用开水冲泡,约半盆即可,待水温达到在40-45摄氏度(手放入不感到烫),每次坐10~30分钟,水温降低时再添加适量的热水,使水保持有效的温度,每天1~2次,10天为一疗程。不要浸泡睾丸,以免影响精子的质量。治疗期间多喝水,不要久坐久骑,不吃刺激性的食物,不吸烟喝酒,有规律的性生活。
药效分析: 连翘味苦,微寒。归肺、心、小肠经。主治:清热解毒,消肿散结。用于痈疽,瘰疬,热淋尿闭;牡丹皮性凉,味辛苦,有清热,凉血、和血、清瘀的功效;赤芍性苦,微寒,主治清热凉血;活血祛瘀。有崩带淋浊、瘀滞胁痛、疝瘕积聚等功效;白茅根性甘、寒,入肺、胃、小肠经,主治:凉血止血,清热解毒。用于尿血,热淋,水肿,黄疸,小便不利,热病烦渴等;黄柏为常用中药,其性寒、味苦,具清热燥湿、泻火解毒等功效,常用于湿热泻痢、黄疸以及热痹、热淋等症;木通性苦,性寒,入心经、小肠经、膀胱经。有清心火,利小便,通经下乳之功效;川牛膝味甘、微苦,,归肝、肾经,主治逐瘀通经,通利关节,利尿通淋;虎耳草微辛苦,性寒,祛风清热,凉血解毒;大黄性味苦寒,归脾、胃、大肠、肝、心包经,有攻积滞、清湿热、泻火、凉血、祛瘀、解毒的功效,主治湿热泻痢、黄疸、淋病、水肿腹满、小便不利; 丹参味苦,气微寒,入心、脾二经,有活血通经 、排脓生肌,理骨筋酸痛之功效;细辛味辛辣麻舌,性温,归心、肺、肾经,有祛风、散寒、温肺、行水、开窍的作用。主治风冷头痛,鼻渊,齿痛,痰饮咳逆,风湿痹痛。王不留行性苦,平,归肝、肾经。有活血通经,利尿通淋的功效;败酱草性味:性凉,味辛、苦。主治:清热解毒,祛瘀排脓。有报道,本品能解除前列腺局部肌肉血管痉挛,增加前列腺分泌,以清热利湿,分清泌浊;荔枝核入肝经,味辛能行,味苦能泄,性温祛寒,有疏肝理气、行气散结、散寒止痛之功;水蛭性咸苦,平,有毒,含有水蛭素,具有活血、散瘀、通经的功效;莪术性辛、苦,温, 归肝、脾经。具有行气破血,消积止痛的功效。琥珀粉归小肠经、膀胱、脾经,味甘平,无毒。有镇静安神、利尿功效;滑石味甘、淡,归膀胱、肺、胃经,利尿通淋,清热解暑,祛湿敛疮;萹蓄味苦,微寒,归膀胱经,有苦降下行,通利膀胱,苦燥又能杀虫除湿止痒,主要用于淋痛及湿疹;地龙适用于湿热下注,热淋涩痛。
药效学实验:
通过对168名慢性前列腺炎患者应用本发明中药颗粒进行中药坐浴治疗取得满意疗效。
一般资料:本组资料共计168例,年龄17~65岁,平均46岁,平均病程1个月~4年。随机分为观察组84例(中药坐浴)和对照组84例(温水坐浴)。病例分布见表1
表1
所有患者均进行直肠指诊,检查前列腺大小、质地、压痛等情况。全部患者均有不同程度的前列腺压痛。所有患者均行肛门指诊和前列腺液常规检查确诊,依据美国国立卫生研究院(NIH)前列腺炎的诊断标准进行分类,Ⅱ型69例(15.2%);Ⅲ型386例(84.8%),其中Ⅲa型337例,Ⅲb型49例。治疗前及治疗4~6周后分别进行前列腺炎症状指数评分(CPSI):1~14分为轻度;15~30分为中度;31~43分为重度。两组患者在年龄、病程、病情、细菌培养等方面比较差异均无统计学意义(P>0.05),具有可比性。
治疗方法:所有患者规律性药物治疗4~6周的基础上,观察组行中药温水坐浴,将中药颗粒剂倒入盆中,用开水冲泡,约半盆即可,待水温达到在40-45摄氏度(手放入不感到烫),,每次坐10~30分钟,水温降低时再添加适量的热水,使水保持有效的温度,每天1~2次,10天为一疗程。不要浸泡睾丸,以免影响精子的质量。治疗期间多喝水,不要久坐久骑,不吃刺激性的食物,不吸烟喝酒,有规律的性生活。对照组方法同上,用清水坐浴。
观察指标:治疗前后每周各做1次前列腺液常规检查(EPS)痊愈:症状程度评分较治疗前减少90%以上,EPS镜检WBC消失或<10 HP-1。显效:症状程度评分较治疗前减少60%~89%,EPS镜检结果明显好转。有效:症状程度评分较治疗前减少30%~59%,EPS镜检有改善。无效:症状程度评分较治疗前减少不足30%,EPS镜检无变化。会阴、阴茎、尿道、耻骨部等部位疼痛是否缓解。排尿是否有尿急、尿频、尿痛和夜尿增多等表现,以及是否有性功能障碍、焦虑、抑郁、失眠、记忆力下降等症状。
统计学分析:患者治疗前后症状程度比较用SPSS 10.0软件包作行×列表资料χ2检验,计量资料以均数土标准差()表示,采用t检验或x2检验,以P<0.05为差异有统计学意义。
结果:患者治疗4~6周后显效139例(82.73%),其中Ⅱ型29例,Ⅲ型116例;有效24例(14.28%),其中Ⅱ型3例,Ⅲ型21例;无效5例(2.97%),其中Ⅱ型1例,Ⅲ型4例。总有效率97.02%。临床症状缓解比例见表2
表2
治疗前后症状变化具有显著性差异(P<0.05)。
分析:
前列腺坐浴,是治疗前列腺炎的一种有效的物理疗法,是一种简单易行的治疗方案,其以操作简单、效果明显的特点,配合中药有很好的疏通经络、活血化瘀效果,可以起到对疾病的缓解保健作用。
前列腺痛,其原因有学者认为是尿道肌和前列腺肌或盆底肌的真性、痉挛性和收缩所致的紧张性疼痛,亦称为“骨盆底张力性肌痛”,为非感染性疾病,不应使用抗生素,治疗可选用中成药活血化淤治疗,并加用α1受体阻滞剂减轻尿道阻力的作用,从而缓解前列腺炎症状。
随着中医微观辨证的兴起,清热利湿与化淤散结两者结合成为了治疗慢性前列腺炎的主要方式。清热利湿解毒药可以将炎性病灶消除,以实现炎性分泌物的对外排出。慢性前列腺炎所引起的腺管水肿,腺管阻塞、腺泡及间质充血腺液滞留、炎性反应包裹及间质纤维化,在治疗过程中可配合活血化淤药物以取得较好的治疗效果。
本发明以上诸药并用,共奏清热利湿、化淤散结之效。其重点在于实现前列腺局部的血液循环,以保证病变组织炎性分泌物能够被顺利地引流,实现了炎性反应以及病灶的彼此间的作用,有很好的临床效果。
上面所述的实施例仅是对本发明的优选实施方式进行描述,并非对本发明的构思和保护范围进行限定,在不脱离本发明设计构思的前提下,本领域中普通工程技术人员对本发明的技术方案作出的各种变型和改进,均应落入本发明的保护范围。
Claims (1)
1.一种用于慢性前列腺炎坐浴的中药颗粒剂,其特征是:由以下中药原料按重量份研磨成粉末状,制成颗粒剂:连翘30、牡丹皮20、赤芍20、白茅根30、黄柏20、木通15、川牛膝15、虎耳草20、大黄30、丹参20、细辛10、王不留行20、败酱草40、荔枝核15、水蛭20、莪术20、琥珀粉20、滑石30、萹蓄20、地龙20。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410154649.9A CN103908637B (zh) | 2014-04-17 | 2014-04-17 | 一种用于慢性前列腺炎坐浴的中药颗粒剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410154649.9A CN103908637B (zh) | 2014-04-17 | 2014-04-17 | 一种用于慢性前列腺炎坐浴的中药颗粒剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103908637A true CN103908637A (zh) | 2014-07-09 |
CN103908637B CN103908637B (zh) | 2016-11-23 |
Family
ID=51034840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410154649.9A Expired - Fee Related CN103908637B (zh) | 2014-04-17 | 2014-04-17 | 一种用于慢性前列腺炎坐浴的中药颗粒剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103908637B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1374107A (zh) * | 2001-12-29 | 2002-10-16 | 郑国芃 | 一种治疗前列腺炎、增生、肥大的中药 |
CN1615950A (zh) * | 2004-09-20 | 2005-05-18 | 史士昊 | 一种治疗慢性前列腺炎的中药坐浴制剂及其制备方法与应用 |
-
2014
- 2014-04-17 CN CN201410154649.9A patent/CN103908637B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1374107A (zh) * | 2001-12-29 | 2002-10-16 | 郑国芃 | 一种治疗前列腺炎、增生、肥大的中药 |
CN1615950A (zh) * | 2004-09-20 | 2005-05-18 | 史士昊 | 一种治疗慢性前列腺炎的中药坐浴制剂及其制备方法与应用 |
Non-Patent Citations (1)
Title |
---|
张奎军等: "慢性前列腺炎中医治疗进展", 《辽宁中医杂志》 * |
Also Published As
Publication number | Publication date |
---|---|
CN103908637B (zh) | 2016-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102319327B (zh) | 内外兼治治疗糖尿病足的中药 | |
CN102120017A (zh) | 治疗子宫肌瘤的中药制剂 | |
CN102949569B (zh) | 一种治疗前列腺增生引起尿频、尿急、尿痛的中药组合物 | |
CN103656377B (zh) | 一种内外兼治慢性前列腺炎的中药药物 | |
CN104189267A (zh) | 治疗肾结石的中药组合物及其制备方法 | |
CN101099802A (zh) | 一种治疗骨质增生性疾病的外用搽剂 | |
CN104056105B (zh) | 一种治疗前列腺炎的中药汤剂 | |
CN102872416B (zh) | 一种治疗慢性前列腺炎的中药坐洗液 | |
CN103301305A (zh) | 一种用于治疗前列腺肥大的中药 | |
CN103908637B (zh) | 一种用于慢性前列腺炎坐浴的中药颗粒剂 | |
CN103495122B (zh) | 一种治疗泌尿系结石的中药 | |
CN102988788A (zh) | 一种治疗慢性盆腔炎的中药及灌肠护理方法 | |
CN103110756B (zh) | 一种治疗肾性血尿的中药组合物 | |
CN102552604A (zh) | 一种治疗前列腺炎和前列腺增生的药物 | |
CN105031310A (zh) | 一种治疗风寒湿痹的药物及其制备方法 | |
CN104435913A (zh) | 一种治疗前列腺炎的中药组合物 | |
CN102961710A (zh) | 一种用于治疗慢性前列腺炎的纯中药复方制剂及其制备方法 | |
CN103417714B (zh) | 一种用于前列腺疾病的中药组合物 | |
CN103330793B (zh) | 一种治疗慢性盆腔炎的中药灌肠剂 | |
CN102688456B (zh) | 一种治疗慢性前列腺炎的中药组合物 | |
CN102641446A (zh) | 一种用于治疗前列腺疾病的中药及其制备方法 | |
CN106215095A (zh) | 治疗肾虚血瘀证型前列腺增生的中药制剂 | |
CN104825729A (zh) | 一种治疗前列腺炎的中药制剂 | |
CN106421125A (zh) | 一种治疗前列腺增生的中药 | |
CN106075180A (zh) | 一种治疗椎管内麻醉术后尿潴留的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20161123 |
|
CF01 | Termination of patent right due to non-payment of annual fee |